Pharmaceutical Technology

MAY 25, 2023

The Medicines and Healthcare products Regulatory Agency (MHRA) aims to launch a pilot genetic biobank that will gather patient data to associate drug-related adverse events to their genetic makeup. The Yellow Card biobank will launch as a joint venture with the UK-government funded entity Genomics England on June 1.

Biobanking 130

Biobanking Genetics Genome Project Genome 130

The Pharma Data

MARCH 1, 2022

to build a scalable data, analytics, and infrastructure platform This collaboration aims at capturing translational disease insights from large external healthcare biobanks and maximizing value of data for drug discovery and precision medicine. Boehringer Ingelheim partners with Lifebit Biotech, Ltd.

Biobanking 52

Biobanking Genome Genomics Genome Project 52

pharmaphorum

JANUARY 26, 2023

In his various commercial roles, Ward has served as a key contributor to many of the world’s largest genomics projects, including Genomics England’s 100,000 Genome Project, the Estonian Genome Project, and the whole genome sequencing of the 500,000 UK Biobank samples.

Genome 122

Genome Genomics Genome Project Genetics 122

pharmaphorum

JANUARY 24, 2023

The same is becoming true for the healthcare industry, and one of the first major breakthroughs in the area was the 100,000 Genomes Project. The information gathered from the project is still providing insights today, a decade later.

Genetics 90

Genetics Drugs Genome Project Biobanking 90

Drug Discovery World

APRIL 4, 2024

To date, the samples for the Biobank have been genotyped using microarray-based methods. The post Estonia National Biobank to sequence 10,000 whole genomes appeared first on Drug Discovery World (DDW).

Biobanking 52

Biobanking Genome Genomics Genome Project 52

Drug Discovery World

NOVEMBER 7, 2022

One might argue that this all started getting exciting with the launch of the Human Genome Project, which the National Human Genome Research Institute consider to be one of the greatest scientific feats in history 1. DDW’s Megan Thomas observes developments of accessibility in this sector and the potential impact. .

Genome 98

Genome Genomics Development Genetics 98

Drug Discovery World

SEPTEMBER 20, 2022

We’re delighted to be working with Genomics England to demonstrate how PacBio HiFi sequencing can help identify the genetic causes of rare disease that remain undiagnosed after short read sequencing. This study is also part of our broader efforts to demonstrate the use case of long read sequencing in identifying rare diseases.

Gene Therapy 52

Gene Therapy Gene Genome Genomics 52